Literature DB >> 7398040

Composition of serum very-low-density and high-density lipoproteins in diabetes.

J Gabor, M Spain, N Kalant.   

Abstract

We examined the cholesterol/protein ratio and the apoprotein composition of serum lipoproteins in a randomly selected population of maturity-onset diabetics and in a group of nondiabetics of similar age. We found no differences in cholesterol distribution between the groups as a whole, but diabetics with above-normal low-density lipoproteins (LDL) had decreased concentrations of high-density lipoprotein (HDL) cholesterol. In the diabetics as a whole, there was an increase in the cholesterol/protein ratio in HDL, a negative correlation between the amounts of LDL cholesterol and HDL cholesterol, an increase in the proportion of apolipoprotein C in very-low-density lipoprotein (VLDL), and a decrease in the proportion of the apolipoprotein AI component of HDL. In diabetic subjects with increased VLDL, there was an increase in the relative amount of apolipoprotein CIII, and a consequent decrease in the ratio of apolipoprotein CII/apolipoprotein CIII in the VLDL. In both diabetic and control subjects, apolipoprotein E and cholesterol content of VLDL were linearly related.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 7398040

Source DB:  PubMed          Journal:  Clin Chem        ISSN: 0009-9147            Impact factor:   8.327


  11 in total

1.  Association of plasma triglyceride and C-peptide with coronary heart disease in Japanese-American men with a high prevalence of glucose intolerance.

Authors:  R W Bergstrom; D L Leonetti; L L Newell-Morris; W P Shuman; P W Wahl; W Y Fujimoto
Journal:  Diabetologia       Date:  1990-08       Impact factor: 10.122

2.  The distribution profiles of very low density and low density lipoproteins in poorly-controlled male, type 2 (non-insulin-dependent) diabetic patients.

Authors:  R W James; D Pometta
Journal:  Diabetologia       Date:  1991-04       Impact factor: 10.122

Review 3.  Lipoprotein alterations in diabetes mellitus.

Authors:  G M Kostner; I Karádi
Journal:  Diabetologia       Date:  1988-10       Impact factor: 10.122

4.  Lack of a lipoprotein-induced insulin resistance in hepatoma cells in culture.

Authors:  F Rinninger; B Wolf; H U Haering; W Bachmann
Journal:  Diabetologia       Date:  1986-07       Impact factor: 10.122

5.  Alterations of lipids and apolipoprotein CIII in very low density lipoprotein subspecies in type 2 diabetes.

Authors:  Anne Hiukka; Jamila Fruchart-Najib; Eeva Leinonen; Hannele Hilden; Jean-Charles Fruchart; Marja-Riitta Taskinen
Journal:  Diabetologia       Date:  2005-04-30       Impact factor: 10.122

6.  Apolipoprotein H is not affected by in vitro glycosylation.

Authors:  R Gambino; G Ruiu; G Pagano; M Cassader
Journal:  J Protein Chem       Date:  1999-02

Review 7.  Diabetic dyslipidaemia: from basic research to clinical practice.

Authors:  M-R Taskinen
Journal:  Diabetologia       Date:  2003-05-28       Impact factor: 10.122

8.  Apolipoprotein C in type 2 (non-insulin-dependent) diabetic patients with hypertriglyceridaemia.

Authors:  A F Stalenhoef; P N Demacker; J A Lutterman; A van't Laar
Journal:  Diabetologia       Date:  1982-06       Impact factor: 10.122

9.  Dietary effects on very low-density lipoproteins in type 2 (non-insulin-dependent) diabetes mellitus.

Authors:  P Weisweiler; M Drosner; P Schwandt
Journal:  Diabetologia       Date:  1982-08       Impact factor: 10.122

10.  Metabolism of very low- and low-density lipoproteins isolated from normolipidaemic type 2 (non-insulin-dependent) diabetic patients by human monocyte-derived macrophages.

Authors:  R L Klein; T J Lyons; M F Lopes-Virella
Journal:  Diabetologia       Date:  1990-05       Impact factor: 10.122

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.